Mylan Laboratories Rejects Icahn&#39;s $4.9 Billion Buyout Bid
476487
The board of Mylan Laboratories rebuffed the financier Carl C. Icahn&#39;s bid to buy the company yesterday, saying it remained committed to acquiring the brand-name drug maker King Pharmaceuticals.
595579
Influential advisory firm Institutional Shareholder Services has recommended that shareholders vote against billionaire Carl Icahn's sweetened $3 billion buyout offer for Lear Corp.
406523
UBS Global Asset Management told Mylan Laboratories Inc. that Mylan&#39;s proposed acquisition of King Pharmaceuticals Inc. is dilutive to Mylan shareholders and not in the best interests of the investment firm&#39;s
386076
In a letter to the board of directors at Mylan Laboratories (nyse: MYL - news - people ), financier Carl Icahn questioned their silence on the recent financial restatements by King Pharmaceuticals (nyse: KG - news - people ), calling the &quot;lack of
107025
Mylan Laboratories Inc. continued to insist Monday that its $4 billion acquisition of King Pharmaceuticals Inc. was in the company&#39;s best interest, following a meeting last week with Carl Icahn, who opposes the deal.
392324
IntercontinentalExchange Inc.  on Thursday urged CBOT Holdings Inc.  shareholders and members to reject the proposed sale of the company to Chicago Mercantile Exchange Holdings Inc.
443606
Mylan Laboratories Inc. may have found the white knight it needs to check Carl Icahn&#39;s attempts to kill its $4 billion plan to acquire King Pharmaceuticals Inc.
165524
Mylan Laboratories Inc. was one of the few drug makers whose stock closed up Friday with the sector down for a second day as fresh squabbles between veteran financier Carl Icahn and the company&#39;s board erupted.
655597
Auto parts maker Lear Corp.  said  on Monday its shareholders voted down a buyout offer from an  affiliate of billionaire investor Carl Icahn.
205093
Mylan Laboratories Inc. (MYL.N: Quote, Profile, Research) on Monday said its board does not believe discussions with financier Carl Icahn&#39;s about his unsolicited proposal to buy the company are in the company&#39;s best interests.
608996
Generic drug maker Mylan Laboratories Inc.  said on Friday it is raising at least about $993.6 million in a public offering of notes and common shares, with proceeds intended for global operations and potential acquisitions.
254001
Billionaire investor Carl Icahn, who is pressing for board changes at biotechnology company ImClone Systems Inc. , on Wednesday acknowledged that he rejected $36-per-share takeover offer for the company, saying the company is worth more.
425366
Pharmaceutical stocks were in the spotlight Thursday with news that investor Carl Icahn&#39;s was given a green light to buy a sizable chunk of Mylan Laboratories Inc.
358942
BETHPAGE, N.Y. -- Shareholders of Cablevision Systems Corp. rejected on Wednesday a $10.6 billion bid by the company's controlling shareholders, the Dolan family, to take the New York-area cable TV provider private.
360232
Veteran financier Carl Icahn said it was &quot;reprehensible and insulting&quot; that the board of drug maker Mylan Laboratories Inc.
447547
IntercontinentalExchange Inc.  on Thursday urged Chicago Board of Trade  shareholders and members to reject the proposed sale to Chicago Mercantile Exchange Holdings Inc.
271608
SL Green Realty said it would not raise its offer for Reckson Associates Realty to match a competing bid by a group led by the financier Carl C. Icahn.